Financial Snapshot

Revenue
$2.568M
TTM
Gross Margin
94.58%
TTM
Net Earnings
-$49.10M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
1256.02%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
$201.0M
Q3 2024
Cash
Q3 2024
P/E
-28.54
Nov 29, 2024 EST
Free Cash Flow
-$46.03M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018
Revenue $30.00K $1.316M $0.00 $0.00 $0.00 $0.00
YoY Change -97.72%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018
Revenue $30.00K $1.316M $0.00 $0.00 $0.00 $0.00
Cost Of Revenue
Gross Profit
Gross Profit Margin

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018
Selling, General & Admin $940.0K $18.46M $28.08M $8.340M $2.560M $3.520M
YoY Change -94.91% -34.27% 236.73% 225.78% -27.27%
% of Gross Profit
Research & Development $20.27M $18.38M $61.50M $24.58M $21.51M $14.80M
YoY Change 10.29% -70.12% 150.24% 14.26% 45.34%
% of Gross Profit
Depreciation & Amortization $73.00K $320.0K $800.0K $600.0K $540.0K $480.0K
YoY Change -77.19% -60.0% 33.33% 11.11% 12.5%
% of Gross Profit
Operating Expenses $67.55M $36.83M $89.58M $32.92M $24.07M $18.32M
YoY Change 83.4% -58.89% 172.14% 36.76% 31.39%
Operating Profit -$67.52M -$35.52M -$89.58M -$32.92M
YoY Change 90.11% -60.35% 172.14%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018
Interest Expense -$900.0K $106.0K -$30.00K $100.0K $40.00K
YoY Change -949.06% -453.33% -130.0% 150.0%
% of Operating Profit
Other Income/Expense, Net $13.16M $834.0K -$789.0K $0.00 $700.0K
YoY Change 1477.34% -205.7% -100.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018
Pretax Income -$54.37M -$34.68M -$89.48M -$32.95M -$23.97M -$17.58M
YoY Change 56.76% -61.24% 171.56% 37.46% 36.35%
Income Tax $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$54.37M -$34.68M -$89.48M -$32.95M -$23.97M -$17.58M
YoY Change 56.75% -61.24% 171.58% 37.45% 36.35%
Net Earnings / Revenue -181216.67% -2635.41%
Basic Earnings Per Share -$0.57 -$0.87 -$0.70
Diluted Earnings Per Share -$0.57 -$0.87 -$2.562M -$996.4K -$724.8K -$531.6K

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018
Cash & Short-Term Investments $228.4M $274.4M $254.0M $386.6M $10.00M $20.20M
YoY Change -16.78% 8.01% -34.29% 3766.0% -50.5%
Cash & Equivalents $70.97M $210.5M $254.0M $386.6M $10.00M $20.20M
Short-Term Investments $157.4M $63.90M
Other Short-Term Assets $3.366M $3.300M $7.447M $4.100M $600.0K $600.0K
YoY Change 2.0% -55.69% 81.63% 583.33% 0.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $231.7M $277.7M $261.5M $390.7M $10.50M $20.80M
YoY Change -16.56% 6.2% -33.07% 3620.95% -49.52%
Property, Plant & Equipment $824.0K $800.0K $6.945M $3.800M $4.600M $6.000M
YoY Change 3.0% -88.48% 82.76% -17.39% -23.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $64.78M
YoY Change
Other Assets $638.0K $3.000M $250.0K $400.0K $600.0K $800.0K
YoY Change -78.73% 1100.0% -37.5% -33.33% -25.0%
Total Long-Term Assets $1.462M $3.700M $71.98M $4.100M $5.100M $6.700M
YoY Change -60.49% -94.86% 1655.49% -19.61% -23.88%
Total Assets $233.2M $281.4M $333.5M $394.8M $15.60M $27.50M
YoY Change
Accounts Payable $1.475M $3.500M $2.078M $2.600M $3.500M $800.0K
YoY Change -57.86% 68.43% -20.08% -25.71% 337.5%
Accrued Expenses $916.0K $1.700M $12.81M $6.200M $2.900M $1.500M
YoY Change -46.12% -86.73% 106.68% 113.79% 93.33%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $800.0K $11.50M $2.800M
YoY Change -100.0% -93.04% 310.71%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $2.391M $5.400M $14.89M $9.600M $17.90M $5.100M
YoY Change -55.72% -63.74% 55.13% -46.37% 250.98%
Long-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $37.00K $3.100M $4.760M $2.300M $3.300M $4.200M
YoY Change -98.81% -34.87% 106.96% -30.3% -21.43%
Total Long-Term Liabilities $37.00K $3.100M $4.760M $2.300M $3.300M $4.200M
YoY Change -98.81% -34.87% 106.96% -30.3% -21.43%
Total Liabilities $2.428M $8.500M $19.65M $11.90M $21.30M $9.400M
YoY Change -71.44% -56.75% 65.14% -44.13% 126.6%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018
Basic Shares Outstanding 95.22M 39.96M 28.87M
Diluted Shares Outstanding 95.22M 39.96M 28.87M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $1.4014 Billion

About ARS Pharmaceuticals, Inc.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. The company is headquartered in San Diego, California and currently employs 146 full-time employees. The company went IPO on 2020-12-04. The firm is focused on developing neffy, for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, administered and nasal spray. Type I allergic reactions are potentially life-threatening hypersensitivity reactions that can occur within minutes of exposure to an allergen and need to be treated immediately to relieve symptoms and prevent further progression.

Industry: Pharmaceutical Preparations Peers: Actinium Pharmaceuticals, Inc. Acumen Pharmaceuticals, Inc. FENNEC PHARMACEUTICALS INC. Akouos, Inc. ARDELYX, INC. Clene Inc. VBI Vaccines Inc/BC Oyster Point Pharma, Inc. Verastem, Inc.